Biocomputing Platforms Ltd Oy

Tekniikantie 14
Espoo, FI-02150
Finland

Phone: +358 9 2517 7340
Fax: +358 10 296 1288
E-Mail: info@bcplatforms.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Biocomputing Platforms Ltd Oy offers data management systems for genetic research studies with support for microsatellite genotype, SNP, haplotype, pedigree and phenotype data. Due to the underlying IBM DB2 SQL database, the system can handle very large data amounts. The system includes connections to commonly-used genotyping/SNP instruments and user interfaces for popular genetic analysis software including quality checks, linkage/QTL, TDT, haplotype and association. Input files for these programs are automatically generated eliminating tedious manual editing.

Cerebricon Ltd.

Microkatu 1
Kuopio, FIN-70211
Finland

Phone: +358 17 368 0801
Fax: +358 17 368 0803

Description:

Cerebricon Ltd. is a fully functional and privately owned contract & collaborative research organization (CRO) that strives to advance knowledge in CNS biology by providing the most comprehensive, highest quality and most cost effective, In Vivo and In Vitro, preclinical models of CNS disease.
All of Cerebrícons in vivo, in vitro, behavioral and histopathological laboratories are proprietal. Cerebricon permanent staff of 26 scientists, pharamacologists and technicians.

Galilaeus Oy

P.O. Box 113
FI-20781 Kaarina
Finland

Phone: +358-2-274 1450
Fax: +358-2-273 1460
E-Mail: galilaeus@galilaeus.fiThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Galilaeus Oy is a process development and contract manufacturing company specialising in fermentation of small molecule pharmaceuticals.

Our process development know-how has resulted in several highly efficient manufacturing processes, which have been out-licensed to API manufacturers. We provide process development also on a fee-for service basis.

In Contract manufacturing we offer fermentation, semi-synthtesis and biotransformation services to pharma and biotech companies. Our GMP facility is equipped with fermentors and down stream equipment to supply APIs from pre-clinical to clinical phase II studies. Cytotoxics and highly potent substance manufacturing is also available.

The core comptetence of Galilaeus is genetic engineering of microbial secondary metabolism. This technology is seamlessly is integrated with traditional strain improvement techniques resulting in superior microbial strain in terms of titre, stability and product profile.

Keywords:
Process development, Contract manufacturing, Strain improvement, biosynthesis, biotransformation, natural compounds